跳至主要内容
临床试验/IRCT2013122815959N1
IRCT2013122815959N1已完成2 期

Comparison of probiotic effect with placebo in prevention of recurrence of intestinal bacterial overgrowth in the irritable bowel syndrome patients

Vice chancellor for research of Ahvaz Jondishapour University of Medical Sciences0 个研究点目标入组 172 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
172

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • patients with irritable bowel syndrome based on ROME III criteria and small intestinal bacterial overgrowth based on positive hydrogen breath test. Exclusion criteria: patients with sensitivity to antibiotics, pregnancy, lactation, previous abdominal surgery, past medical history of hypothyroidism, celiac, malignancy, renal and liver insufficiency, diabetes and inflammatory bowel disease, familial history of colorectal carcinoma, ingestion of immunosuppressives and antibiotics in recent 2 months, ingestion of probiotics for more than 2 weeks in recent 6 months.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research of Ahvaz Jondishapour University of Medical Sciences

相似试验

Effect of probiotic in intestinal bacterial... | 临床试验